COVID-19 vaccine uptake and acceptability during the second phase of vaccine rollout: a community-based survey among household heads in Zamfara state, Nigeria, 2021

Author:

Idris Ahmad SuleimanORCID,Aliyu Hafiz,Usman Rabi,Abubakar Ahmed Tijani,Maijawa Muhammad Abdullahi,Abdullahi Bello Suleiman,Balogun Muhammad Shakir,Olorukooba Abdulhakeem,Umeokonkwo Chukwuma,Maiyaki Abubakar,Sani Muhammad,Yisa Muhammad,Zubair Ismail Hadi,Chinedu Onu Hastings,Jatau Tenmuso David,Sabitu Kabir

Abstract

AbstractIntroductionVaccines have played an important role in the control of infectious diseases globally. COVID-19 vaccine was rolled out in Zamfara State for the public in August 2021. We aimed to determine the level of COVID-19 vaccine uptake, acceptance, and awareness in Zamfara state Nigeria, during the second phase of the COVID-19 roll-out in the community.MethodsWe executed a descriptive cross-sectional study in Zamfara state, Nigeria. We used multistage sampling technique to randomly select 910 household heads between October 12 to December 20, 2021. We used a semi-structured electronic questionnaire to collect data on sociodemographic characteristics, uptake, and acceptance of COVID-19 vaccine. We performed descriptive analysis; calculated frequencies, proportions, and produced tables and figures.ResultsOur 899 respondents had a median age of 48 years (interquartile range: 29.5-66.5). About 78.1% (711) were males. A majority of the respondents were within the age group 50-59 years. Of 897 respondents 47.2% (423) were educated up to the secondary school level.Only 8.9% (81) had received COVID-19 vaccine. Of the 829 unvaccinated respondents, 10.1% (84) accepted to take the vaccine the current week of the interview, 38.4% (318) would it the following week, and 27.4% (227) the following month, while 12.2% (101) of the respondents rejected the vaccine,ConclusionCOVID-19 vaccine had a poor uptake and acceptance rate in Zamfara State during the vaccine rollout. We recommended carefully designed and targeted sensitization campaigns to increase the demand of COVID-19 vaccine in the community.

Publisher

Cold Spring Harbor Laboratory

Reference30 articles.

1. Peiris JSM. Coronaviruses. In: Clinical Virology. Washington, DC, USA: ASM Press; 2016. page 1243–65.

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

4. WHO | Novel Coronavirus – China. WHO 2020;

5. Coronavirus (COVID-19) events as they happen [Internet]. [cited 2020 Sep 27];Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3